🇺🇸 FDA

Company profile · Sponsor

Elicio

Elicio Therapeutics

ELTX · NYSE pharma BOSTON, MA, USA
Pipeline
2
Drugs
0
Patents
4

Quick answer

Elicio (ELTX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker ELTX
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0001601485

Pipeline (2)

Search pipeline →

  1. ELI-002 7P

    Elicio

    Pancreatic Ductal Adenocarcinoma

    phase 2 small molecule active

    1 trial

  2. ELI-002 2P

    Elicio

    Minimal Residual Disease

    phase 1 small molecule completed

    1 trial

Patents (4)

Search patents →

  1. US 12370245

    ALK polypeptides and methods of use thereof

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12247052

    CpG amphiphiles and uses thereof

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12138301

    Compounds including a mutant KRAS sequence and a lipid and uses thereof

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11623002

    ALK polypeptides and methods of use thereof

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Elicio?

Elicio (ELTX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does Elicio sponsor?

We track 2 ClinicalTrials.gov-linked programs for Elicio, including ELI-002 7P and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Elicio company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.